Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Ayurveda Treatment Protocol With Ayurveda spice mix tablet: Ayurveda Spice mix (Tulsimmune) tablet 500 mg One to two tablets two to three times a day with preferably hot water or chewin
Sponsors
Suraj Ayurveda Clinic and Research center
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age Eligible for Study:18 Years to 75, male female 2.Subject must meet the WHO/MOHFW India /ICMR Criteria having symptoms of SARS CoV2 described in WHO Report/groups described by MOHFW India, (Group B,C,D,E mainly) 3.Quarantine/non hospitalized or hospitalized AND Fulfills WHO case definition, including a positive PCR for COVID-19 from any specimen (e.g. respiratory, blood, urine, stool, other bodily fluid) and other analysis.
Exclusion criteria
Exclusion criteria: 1. Active indication and use for one of the investigational products (e.g. HIV positive or active hepatitis B if antiretroviral agents were used ) 2. Allergy or other contraindication or one of the investigational products 3. In the opinion of the clinical team, progression to death is imminent and inevitable within the next 24 hours, irrespective of the provision of treatments. 4. Participant with any immunosuppressive condition or hematological disease 5. Participation in any other A.S.U and H protocol 6. Pregnant woman and lactating mother
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the severity index of symptoms of SARS-CoV 2 patients in public/private hospitals in Maharashtra. 1.Severity of disease in SARS-CoV-2 assessed by No symptoms-1 Mild symptoms-fever, dry cough, myalgia, fatigue, anosmia-2 Moderate symptoms-mild symptoms plus shortness of breath, dyspnoea-3 â?¢Severe symptoms-respiratory insufficiency that requires Oxygen support and mechanical ventilation-4 2. Duration of symptoms in Patients of SARS-CoV-2 measured in days Timepoint: Day 0, day 14 | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in clinical severity if any of SARS-CoV-2 patients among hospitals in Maharashtra measured with whatever possible Investigations done in hospital on admission like CBC/CRP/LFT/RFT/CPK-total/APTT/PT-INR/D-DIMER/LDH/Sr. Ferritin/Sr. Troponin-I/HbA1c/Viral markers IL-6/IgM(optional) pulmonary imaging like Chest X-ray etc, ECG and in due course of hospitalizationTimepoint: Change in Lab testing Pulmonary Imaging etc if any Day 0 day 14 | — |
Countries
India
Contacts
Public ContactDr Akshaya Wagh Dr Pratika Kambale
H.J. Doshi Ghatkopar Hindusabha Hospital
Outcome results
None listed